| Trial ID: | L0833 |
| Source ID: | NCT02992470
|
| Associated Drug: |
Hydrolyzed oyster extract
|
| Title: |
Hydrolyzed Oyster Extract for Liver Health: a Randomized, Double-blind, Placebo-controlled Trial
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver
|
| Interventions: |
Dietary Supplement: Hydrolyzed oyster extract;Dietary Supplement: Placebo
|
| Outcome Measures: |
Change of serum alanine aminotransferase (ALT)Change of serum aspartate aminotransferase (AST);Change of gamma-glutamyl transferase (GGT);Rate of participants with normalized ALT, AST and GGT;Change of serum bilirubin;Change of multi-dimensional fatigue inventory;Change of serum lipid profiles (triglyceride, total cholesterol, High-density lipoprotein and low-density lipoprotein cholesterol);Change of antioxidant enzymes (superoxide dismutase, malondialdehyde, glutathione peroxidase)
|
| Sponsor/Collaborators: |
Korean Medicine Hospital of Pusan National University
|
| Gender: |
All
|
| Age: |
19 Yearsnan
|
| Phases: |
Not applicable
|
| Enrollment: |
96
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care
|
| Start Date: |
12/12/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
9 January 2017
|
| Locations: |
--
|
| URL: |
https://clinicaltrials.gov/show/NCT02992470
|
